InsidersTradesSigma
Track the KALBE FARMA Tbk, PT share price and the full directors' dealings record of the company, a listed equity based in Indonesia. Shares are listed on the ID market, under the oversight of OJK / IDX. Market capitalisation: €36,651.6bn. The latest transaction was disclosed on 24 August 2026 (Purchase). Among the most active insiders: FERDINAND ARYANTO. The full history is free.
Analysts rate KALBE FARMA Tbk, PT Strong Buy (bullish), based on 17 analysts. Average price target: IDR 1,175.29.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
KALBE FARMA Tbk, PT es una empresa farmacéutica indonesia especializada en la producción de medicamentos, productos nutricionales y productos para la salud. Cotiza en la Bolsa de Indonesia (XIDX).